Agah Ramtin
Company insiders · Executive Chairman and CMO · Director · RenovoRx, Inc.
- Reported transaction lines
- 1
- Buy lines
- 1
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-111
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Agah Ramtin Executive Chairman and CMO · Director · RenovoRx, Inc. | RNXT RenovoRx, Inc. | BuyFiling detailsSEC transaction code P Common Stock · Direct ownership · Reported balance after transaction: 848460 · SEC code covers open-market or private transactions · Reflects open market purchases of the Issuer's securities. · Reflects a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $0.925 to $0.9299. | 2026-11-16 | 2026-11-17 | ≈ $46,485.00 50,000 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.